Electronic prescribing influence on calcium supplementation: a randomized controlled trial
- PMID: 20044067
- DOI: 10.1016/j.ajog.2009.10.886
Electronic prescribing influence on calcium supplementation: a randomized controlled trial
Abstract
Objective: The purpose of this study was to determine whether an electronic prescription for over-the-counter calcium supplements increases compliance.
Study design: Two hundred forty-five patients from 19-50 years of age who underwent annual gynecologic examinations were assigned randomly to either verbal counseling about the use of a calcium carbonate with vitamin D supplement (n = 122) or verbal counseling and an electronic prescription (n = 123). Telephone interviews at 3 and 6 months determined compliance.
Results: Women who received the electronic prescription were significantly more likely to use calcium supplementation than control subjects at both 3 and 6 months. At 3 months, 66.0% of women who received an electronic prescription reported compliance (P = .001). At 6 months, 57.0% of the participants were compliant (P = .001). At 6 months, women who were given the electronic prescription were 2.2 times more likely to report having taken the calcium than were control subjects (95% confidence interval, 1.5-3.1).
Conclusion: An electronic prescription for over-the-counter calcium supplements is associated with a significant increase in compliance, compared with verbal counseling alone.
Copyright 2010 Mosby, Inc. All rights reserved.
Similar articles
-
Clinical and laboratory safety of one year's use of a combination calcium + vitamin D tablet in ambulatory elderly women with vitamin D insufficiency: results of a multicenter, randomized, double-blind, placebo-controlled study.Clin Ther. 2005 Dec;27(12):1885-93. doi: 10.1016/j.clinthera.2005.12.010. Clin Ther. 2005. PMID: 16507374 Clinical Trial.
-
Compliance with osteoporosis treatment guidelines in postmenopausal women.Ann Pharmacother. 2009 Feb;43(2):242-50. doi: 10.1345/aph.1L464. Epub 2009 Feb 5. Ann Pharmacother. 2009. PMID: 19196838
-
A comparison of calcium, calcitriol, and alendronate in corticosteroid-treated premenopausal patients with systemic lupus erythematosus.J Rheumatol. 2008 Dec;35(12):2344-7. doi: 10.3899/jrheum.080634. Epub 2008 Nov 1. J Rheumatol. 2008. PMID: 19004038 Clinical Trial.
-
Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial.J Am Geriatr Soc. 2007 May;55(5):752-7. doi: 10.1111/j.1532-5415.2007.01161.x. J Am Geriatr Soc. 2007. PMID: 17493196 Clinical Trial.
-
Calcium and vitamin D in the prevention and treatment of osteoporosis - a clinical update.J Intern Med. 2006 Jun;259(6):539-52. doi: 10.1111/j.1365-2796.2006.01655.x. J Intern Med. 2006. PMID: 16704554 Review.
Cited by
-
Vitamin D supplementation for prevention of mortality in adults.Cochrane Database Syst Rev. 2014 Jan 10;2014(1):CD007470. doi: 10.1002/14651858.CD007470.pub3. Cochrane Database Syst Rev. 2014. PMID: 24414552 Free PMC article.
-
Improving Folic Acid Supplementation for Women of Childbearing Age With Epilepsy.Neurol Clin Pract. 2025 Aug;15(4):e200485. doi: 10.1212/CPJ.0000000000200485. Epub 2025 Jun 4. Neurol Clin Pract. 2025. PMID: 40510872
-
Adherence to Calcium and Vitamin D supplementations: results from the ADVICE Survey.Clin Cases Miner Bone Metab. 2012 Sep;9(3):157-60. Epub 2012 Dec 20. Clin Cases Miner Bone Metab. 2012. PMID: 23289030 Free PMC article.
-
Interventions to improve osteoporosis medication adherence and persistence: a systematic review and literature appraisal by the ISPOR Medication Adherence & Persistence Special Interest Group.Osteoporos Int. 2013 Dec;24(12):2907-18. doi: 10.1007/s00198-013-2364-z. Epub 2013 May 1. Osteoporos Int. 2013. PMID: 23636230
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources